Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Acute Lymphoblastic Leukemia in Children.

Trial Profile

Treatment of Acute Lymphoblastic Leukemia in Children.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2018

At a glance

  • Drugs Pegaspargase (Primary) ; Asparaginase; Cyclophosphamide; Cytarabine; Cytarabine; Dexamethasone; Dexrazoxane; Doxorubicin; Etoposide; Folinic acid; Hydrocortisone; Mercaptopurine; Methotrexate; Methotrexate; Methylprednisolone; Prednisolone; Prednisone; Vincristine
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions
  • Sponsors Enzon Pharmaceuticals
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 23 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
    • 23 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top